← Back
$ORIC All transactions

Oric Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$38K

Shares

3,200

Price

$12

Filed

Jan 20

Insider

Name

Heyman Richard A.

Title

CIK

0001584759

Roles

Director

Transaction Details

Transaction Date

2026-01-16

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

213,072

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. | Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.

Filing Info

Accession No.

0001584759-26-000006

Form Type

4

Issuer CIK

0001796280

Heyman Richard A.'s History

Date Ticker Type Value
2026-02-17 ELVN $32K
2026-02-12 ELVN A $0
2026-01-20 ELVN $14K
2026-01-20 ELVN $19K
2026-01-16 ORIC $42K
2026-01-16 ORIC $38K
2026-01-09 ELVN $107K
2026-01-08 ELVN $40K
2026-01-08 ELVN $201K
2026-01-02 ORIC A $0

Other Insiders at ORIC (90d)

Insider Bought Sold Last
Piscitelli Dominic
Chief Financial Officer
$703K 2026-02-24